Résultats de la recherche - 2 results
A Comparative Immunogenicity and Safety Trial of Two Different Schedules of Single-visit Intradermal Rabies Post-exposure Vaccination Following a Single-visit Pre-exposure Vaccination.
for immunogenicity was the percentage of subjects with an adequate antibody level (>0.5 IU /mL) seven days after the booster doses. The safety endpoint was the proportion of participants developing ...
Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days.
with an adequate antibody level >0.5 IU /mL seven days after the booster injection. The safety endpoint was the proportion of participants developing adverse reactions following the primary ...